Severe pembrolizumab-induced gastritis in a patient with lung adenocarcinoma.

Cristina Pérez Santamaría Guillermo Castillo-LópezIsabel Curto-GarcíaPatricia Gómez IglesiasMercedes Lumbreras CabreraLourdes Carreira Guillán

Published in: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2021)

Cancer immunotherapy is an increasingly common treatment option based on anti-tumor immune response. However, a challenge is arising regarding potential, as yet poorly recognized immune-mediated adverse effects.

Keyphrases

immune response
helicobacter pylori
high glucose
drug induced
helicobacter pylori infection
case report
diabetic rats
toll like receptor
endothelial cells
combination therapy
inflammatory response